Group photo showing SYMPATH symposium speakers, SYMPATH consortium members, SYMPATH advisory board members and EC project officer.
left to right: Kuldip Dave, Dieter Willbold, Alexandra Kutzelnigg, Werner Poewe, Christine Mannhalter, Vera Bürger, Caroline Thun- Hohenstein, Dieter Volc, Nour Majbour, Annemarie Schallerbauer-Peter, Günther Staffler, Gergana Galabova, Iris Grünert, Wassilios Meissner, Joaquim Ferreira, Tuyen Bujnicki, Oliver Bannach, Roberto De Marzi, Stefan Grünert, Jürgen Sautter, Matthew Spencer, Afitap Derya Köprülü, Natalia Lyashenko, Sweta Bajaj
The “SYMPATH Symposium on Targeting Synucleinopathies” took place at the Research Institute of Molecular Pathology (IMP) in Vienna on 28th March 2017.
The event was a great success, bringing together world-leading experts to discuss recent progress in developing new potential biomarkers and therapeutic concepts, including vaccines, for Parkinson´s disease (PD) and multiple system atrophy (MSA). Over 100 people attended the symposium which, alongside the presentations, also hosted a poster session and an interactive exhibition.